SQZ BIOTECHNOLOGIES COMPANY Share-based Payment Arrangement, Expense
SQZ BIOTECHNOLOGIES COMPANY reported Share-based Payment Arrangement, Expense of $983.00 thousand for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-11-08.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2023-11-08
- SQZ BIOTECHNOLOGIES COMPANY share-based payment arrangement, expense for the quarter ending 2023-09-30 was $983.00K, a 58.63% decline year-over-year.
- SQZ BIOTECHNOLOGIES COMPANY share-based payment arrangement, expense for the quarter ending 2023-06-30 was $1.15M, a 50.11% decline year-over-year.
- SQZ BIOTECHNOLOGIES COMPANY share-based payment arrangement, expense for the quarter ending 2023-03-31 was $695.00K, a 64.30% decline year-over-year.
- SQZ BIOTECHNOLOGIES COMPANY share-based payment arrangement, expense for the quarter ending 2022-12-31 was $1.77M, a 23.31% decline year-over-year.
- SQZ BIOTECHNOLOGIES COMPANY share-based payment arrangement, expense for fiscal 2022 was $8.40M, a 1.20% decline from fiscal 2021.
- SQZ BIOTECHNOLOGIES COMPANY share-based payment arrangement, expense for fiscal 2021 was $8.51M, a 136.12% increase from fiscal 2020.
- SQZ BIOTECHNOLOGIES COMPANY share-based payment arrangement, expense for fiscal 2020 was $3.60M, a 70.87% increase from fiscal 2019.
- SQZ BIOTECHNOLOGIES COMPANY share-based payment arrangement, expense for fiscal 2019 was $2.11M.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|---|
| 2023-09-30 | $983.00K 10-Q · filed 2023-11-08 | $2.13M derived: sum of 2 quarters · filed 2023-11-08 | $2.83M 10-Q · filed 2023-11-08 | $4.60M derived: sum of 4 quarters · filed 2023-11-08 |
| 2023-06-30 | $1.15M 10-Q · filed 2023-08-10 | $1.85M 10-Q · filed 2023-08-10 | $3.62M derived: sum of 3 quarters · filed 2023-08-10 | $6.00M derived: sum of 4 quarters · filed 2023-11-08 |
| 2023-03-31 | $695.00K 10-Q · filed 2023-05-10 | $2.47M derived: sum of 2 quarters · filed 2023-05-10 | $4.84M derived: sum of 3 quarters · filed 2023-11-08 | $7.15M derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-12-31 | $1.77M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | $4.15M derived: sum of 2 quarters · filed 2023-11-08 | $6.46M derived: sum of 3 quarters · filed 2023-11-08 | $8.40M 10-K · filed 2023-03-22 |
| 2022-09-30 | $2.38M 10-Q · filed 2023-11-08 | $4.68M derived: sum of 2 quarters · filed 2023-11-08 | $6.63M 10-Q · filed 2023-11-08 | $8.94M derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-06-30 | $2.31M 10-Q · filed 2023-08-10 | $4.25M 10-Q · filed 2023-08-10 | $6.57M derived: sum of 3 quarters · filed 2023-08-10 | $9.35M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $1.95M 10-Q · filed 2023-05-10 | $4.26M derived: sum of 2 quarters · filed 2023-05-10 | $7.04M derived: sum of 3 quarters · filed 2023-05-10 | $8.87M derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | $2.31M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | $5.09M derived: sum of 2 quarters · filed 2023-03-22 | $6.92M derived: sum of 3 quarters · filed 2023-03-22 | $8.51M 10-K · filed 2023-03-22 |
| 2021-09-30 | $2.78M 10-Q · filed 2022-11-09 | $4.61M derived: sum of 2 quarters · filed 2022-11-09 | $6.19M 10-Q · filed 2022-11-09 | $7.55M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $1.83M 10-Q · filed 2022-08-04 | $3.41M 10-Q · filed 2022-08-04 | $4.76M derived: sum of 3 quarters · filed 2022-08-04 | $5.56M derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | $1.58M 10-Q · filed 2022-05-10 | $2.94M derived: sum of 2 quarters · filed 2022-05-10 | $3.73M derived: sum of 3 quarters · filed 2022-05-10 | $4.49M derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | $1.35M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-16 | $2.15M derived: sum of 2 quarters · filed 2022-03-16 | $2.90M derived: sum of 3 quarters · filed 2022-03-16 | $3.60M 10-K · filed 2022-03-16 |
| 2020-09-30 | $796.00K 10-Q · filed 2021-11-10 | $1.55M derived: sum of 2 quarters · filed 2021-11-10 | $2.25M 10-Q · filed 2021-11-10 | $2.90M derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | $754.00K 10-Q · filed 2021-08-04 | $1.45M 10-Q · filed 2021-08-04 | $2.10M derived: sum of 3 quarters · filed 2021-08-04 | $2.59M derived: sum of 4 quarters · filed 2021-08-04 |
| 2020-03-31 | $698.00K 10-Q · filed 2021-05-11 | $1.34M derived: sum of 2 quarters · filed 2021-05-11 | $1.84M derived: sum of 3 quarters · filed 2021-05-11 | |
| 2019-12-31 | $647.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | $1.14M derived: sum of 2 quarters · filed 2021-03-18 | $2.11M 10-K · filed 2021-03-18 | |
| 2019-09-30 | $491.00K 10-Q · filed 2020-12-10 | $1.46M 10-Q · filed 2020-12-10 |